Inactive Instrument

Other languages EXACT Therapeutics AS Oslo Bors

Equities

NO0010852213

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Financial calendar	23/05
EXACT Therapeutics : Successful placement of NOK 25 million share issue	25/04
EXACT Therapeutics AS Reports Earnings Results for the Full Year Ended December 31, 2023	19/04
Additional promising clinical data from EXACT Therapeutics' ongoing ACTIVATE study presented at AACR Annual Meeting	10/04
EXACT Therapeutics to Present at 2024 American Association for Cancer Research (AACR) Annual Meeting	07/03
EXACT Therapeutics AS - Share capital increase registered	20/12
EXACT Therapeutics presenting at DNB Nordic Healthcare conference December 14	14/12
EXACT Therapeutics : announces successful placement of NOK 25 million share issue	01/12
EXACT Therapeutics AS: Primary insider notices	01/12
EXACT Therapeutics AS: Private placement successfully placed	01/12
EXACT Therapeutics AS: Contemplated Private Placement	30/11
Exact Therapeutics Wins Regulatory Approvals for Patient Recruitment in Dose Expansion Study	31/23/31
EXACT Therapeutics receives regulatory approval to start recruitment of patients at Oslo University hospital	31/23/31
EXACT Therapeutics AS - Issuance of share options	16/23/16
EXACT Therapeutics CEO Dr Per Walday to participate in international Drug Delivery panel	12/23/12
EXACT Therapeutics AS Reports Earnings Results for the Half Year Ended June 30, 2023	28/23/28
EXACT Therapeutics : Interim Report 2023	28/23/28
EXACT Therapeutics announces first half 2023 interim results	28/23/28
EXACT Therapeutics announces appointment of Caspar Foghsgaard as SVP Commercial & Business Development	27/23/27
EXACT Therapeutics AS Announces Appointment of Caspar Foghsgaard as SVP Commercial & Business Development Effective 1 November 2023	27/23/27

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages EXACT Therapeutics AS Oslo Bors

Equities

NO0010852213

Other languages

Filters